Abstract:Three plasmid constructs were prepared that express small interfering RNAs (siRNAs) targeted to sequences encoding the ribonucleoprotein member, nucleoprotein (NP) and/or PA, of influenza virus genome. The antiviral properties of siRNAs against the H5N1 strain of influenza virus were studied by evaluating their capacity to silence expression of target genes as well as their effect on influenza virus-induced apoptosis in Madin-Darby canine kidney cells, chicken embryo fibroblast cells, and embryonated chicken eggs in a transient replication model. The results demonstrated that all three siRNAs expressing plasmids efficiently transcribed the short hairpin RNAs and inhibited expression of the NP or PA proteins measured by northern blot and western blot analyses, respectively, in the transfected cells. We also found that the integrated siRNA expression plasmid pEGFP/NP+PA, which we constructed for the first time to synchronously target NP and PA segments of the influenza virus genome, could more efficiently inhibit synthesis of influenza virus detected by cytopathogenic effects, hemagglutinin, and plaque-forming unit assays in the transfected cells. Furthermore, the integrated siRNA expression plasmid pEGFP/NP+PA could remarkably interrupt the cellular apoptotic course caused by influenza virus, which protected infected cells from apoptotic damage. In contrast, a control siRNA expression plasmid, pEGFP/HK, could neither inhibit the protein expression and production of influenza virus nor interrupt the cell apoptotic course mediated by influenza virus. These results demonstrate that RNA interference (RNAi) can be used to inhibit protein expression and replication of influenza virus and that RNAi treatment holds potential as a new approach to prevent avian influenza.

Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection.

Use of Sirnas to Prevent and Treat Influenza Virus Infection

Inhibition of Influenza Virus Production in Virus-Infected Mice by RNA Interference.

Effective Small Interfering RNAs Targeting Matrix and Nucleocapsid Protein Gene Inhibit Influenza A Virus Replication in Cells and Mice

In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery

Construction of Influenza Virus Sirna Expression Vectors and Their Inhibitory Effects on Multiplication of Influenza Virus.

RNA Interference of Influenza Virus Production by Directly Targeting Mrna for Degradation and Indirectly Inhibiting All Viral RNA Transcription

Inhibition of influenza A virus replication by RNA interference targeted against the PB1 subunit of the RNA polymerase gene

Rapid Identification of Small Interfering Rna That Can Effectively Inhibit the Replication of Multiple Influenza B Virus Strains

795. RNA Interference of Influenza Virus Infection

In Vitro and in Vivo Protection Against the Highly Pathogenic H5N1 Influenza Virus by an Antisense Phosphorothioate Oligonucleotide

RNA interference against influenza A (H1N1) virus

Inhibitory Effect of Small Interfering RNA Specific for a Novel Candidate Target in PB1 Gene of Influenza A Virus.

Targeted recruitment of immune effector cells for rapid eradication of influenza virus infections

RNA Secondary Structure as a First Step for Rational Design of the Oligonucleotides towards Inhibition of Influenza A Virus Replication

Viral RNA Polymerase: A Promising Antiviral Target for Influenza A Virus

Effective Inhibition of Mrna Accumulation and Protein Expression of H5N1 Avian Influenza Virus NS1 Gene in Vitro by Small Interfering RNAs

Delivery System Targeting Hemagglutinin of Influenza Virus A to Facilitate Antisense-Based Anti-H1N1 Therapy.

High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination

Transportan-derived Cell-Penetrating Peptide Delivers Sirna to Inhibit Replication of Influenza Virus in Vivo

mRNA-encoded Cas13 treatment of Influenza via site-specific degradation of genomic RNA